As per our report, the global anatomic pathology market is predicted to reach USD 31.29 billion by 2029 from USD 23.21 billion in 2024. The market is forecasted to grow at a CAGR of 6.16% during the forecast period. The use of anatomic pathology with biomarkers in diagnosing cancer is hugely impacting the market's growth rate positively.
Y-O-Y demand to improve the diagnostic procedures in clinical centers, increasing concern towards health and priority for early diagnosis and a rise in disposable income in urban areas is expected to boost the market’s growth rate. The growing adoption of the latest technologies and the launch of innovative techniques in the medical sector are estimated to favor the anatomic pathology market growth. In addition, the growing prevalence of effective treatment procedures and the promotion of the patient's well-being after surgeries create opportunities for the anatomic pathology market. Increasing investments in hospital construction by the government is likely to bolster the anatomic pathology market.
The shortage of skilled professionals to examine tissues and cells accurately in anatomic pathology in some countries is hampering the growth rate of the worldwide market. The high cost associated with diagnostic tests for anatomic pathology is another key factor hindering market growth. Unfavorable reimbursement policies for anatomic pathology tests in some countries are impeding market growth. The slow adoption of new technologies and stringent regulatory environment for anatomic pathology is further impacting the market growth negatively. Limited access to technological advancements in underdeveloped and developing countries, changing healthcare policies, and ethical and legal issues related to patient privacy and consent are limiting the growth rate of the market.
The anatomic pathology market has experienced a mixed impact from the COVID-19 pandemic. On one side, the demand for anatomic pathology tests has grown notably during the COVID-19 pandemic to test the presence of the virus in the human body, which has favored market growth. On the other side, the COVID-19 pandemic has created severe disruption in the supply chain ecosystem and caused a decline in the growth rate of the anatomic pathology market due to the shortages of essential supplies and materials for anatomic pathology labs. During the COVID-19 pandemic, the anatomic pathology labs have had to work continuously to address the increased need to test COVID-19 cases and the anatomic pathology labs have increasingly invested amounts to provide security in terms of PPE kits to the workforce. Likewise, the COVID-19 pandemic has shown a mixed impact on the growth of the anatomic pathology market. However, considering the reduced impact of COVID-19 impact and increased habituation of new normalization by people and companies, the global market for anatomic pathology is predicted to showcase a healthy CAGR in the coming future.
REPORT METRIC |
DETAILS |
Market Size Available |
2024 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Product Type, End-User, Application, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Market Leader Profiled |
F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings |
Based on product type, the instruments segment led the anatomic pathology market in 2023. Changes in lifestyles and food habits, a rise in the incidences of various health disorders, and growing expenditure on healthcare are majorly elevating the growth of the anatomic pathology market. In addition, in the medical sector, there is a growing need to improve diagnostic procedures and analyze the issue with a clear vision to promote effective treatment for the patient, significantly influencing the market growth.
Based on the end-user, the diagnostics lab segment dominated the anatomic pathology market in 2023. Increasing support from private and public organizations in healthcare centers is accelerating the market's demand. Growing awareness of the availability of various diagnostic procedures for many health disorders is likely to outshine the market's growth. In addition, the rise in the number of research institutes in the medical sector is lavishing the development of the anatomic pathology market.
Based on the application, the lymphoma segment led a significant share of the anatomic pathology market owing to the growing adoption of the latest technology in diagnosing and treating the disease. Increasing disposable income, especially in urban areas, and the growing tendency to launch innovative devices in favor of the end-users are ascribed to bolstering the growth of the anatomic pathology market. The rise in the revenue in developed and developing countries also magnifies the significant growth rate of the anatomic pathology market.
Geographically, the North American anatomic pathology market accounted for the leading share in the global market in 2021. The rise in awareness of diagnostic procedures is driving the growth of the anatomic pathology market in North America. Besides, the growing number of research institutes to improve performance boosts the market's demand. As a result, the U.S. is expected to account for most of the share in the North American market during the forecast period.
The APAC anatomic pathology market was right behind the North American market in accounting for the leading share worldwide in 2021 and is predicted to register the fastest CAGR during the forecast period. The growing geriatric population is one factor outshining the business's demand. Also, increasing hospitals' construction with the latest equipment is broadening the growth of the anatomic pathology market.
The Europe anatomic pathology market witnessed the fastest growth rate in the past few years, and it is deemed to have a significant growth rate in the coming years. Furthermore, acceptance of the latest technologies and implementation of new devices at a high success rate is escalating the European market demand.
The Latin American anatomic pathology market is forecasted to grow at a CAGR of 6.93% from 2024 to 2029.
The anatomic pathology market in the Middle East and Africa is expected to have slight variations in the growth rate.
Noteworthy companies in the global anatomic pathology market profiled in this report are F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine technical Co. Ltd., Metropolis, and BISWorld's Pathology Services.
Roche Company completed the acquisition of spark therapeutics in 2019.
Sarepta Therapeutics Company collaborated with Roche in Dec 2019. As a result, Roche has signed an agreement to use investigation gene therapy outside the US, developed by Sarepta.
The global anatomic pathology market has been segmented in this research report based on the product type, end-user, application, and region.
By Product
By End-User
By Application
By Region
Frequently Asked Questions
Geographically, the North American anatomic pathology market accounted for the largest share of the global market in 2023.
The global anatomic pathology market is estimated to grow at a CAGR of 6.16% from 2024 to 2029.
F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine technical Co. Ltd., Metropolis, and BISWorld's Pathology Services are some of the prominent companies operating in the global anatomic pathology market.
As per our research report, the global anatomic pathology market size is estimated to be USD 31.29 billion by 2029 from USD 23.21 billion in 2024.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region